Bottom line
Is ARUVX a good fund? The bottom line
ARUVX is the Investor share class of Arga Value Fund, a managed large value mutual fund from SEI.
Its expense ratio is 1.05% — about $105 a year on every $10,000 invested, more expensive than 71% of large value funds we track.
With $7.3 million in net assets and 48 holdings, its largest position is Elevance Health, Inc. (4.6%) and the top 10 make up 35.4% of the portfolio.
What to watch
- Expensive for its category (1.05%)
- 12b-1 marketing fee of 0.25% a year
- Small fund ($7.3 million) — small funds are likelier to close
Updated Nov 19, 2026
What ARUVX invests in
The ARGA Value Fund (the Fund) seeks long-term capital appreciation.
Under normal circumstances, the Fund will invest at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of U.S. companies and in other financial instruments, such as shares of exchange-traded funds (ETFs), that have similar economic characteristics to such securities. This 80% investment policy can be changed by the Fund upon 60 days prior written notice to shareholders. For purposes of the 80% policy, the Fund may purchase stocks issued by companies of any size, but it typically focuses its investments on large-cap stocks. The Fund considers a company to be a U.S. company if any of the following apply: (i) its securities are traded principally in the United States; (ii) it is organized under the laws of, or has a principal office in, the United States; or (iii) while traded on any market, it derives at least 50% of its revenues or profits…
From the fund's prospectus (filed Apr 30, 2026).
What ARUVX costs
On a $10,000 investment, ARUVX's 1.05% expense ratio costs about $105 a year. The prospectus estimates $5,048 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.
ARUVX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Elevance Health, Inc. | 4.56% |
| 2 | Biomarin Pharmaceutical Inc. | 4.41% |
| 3 | Mohawk Industries, Inc. | 3.93% |
| 4 | T. Rowe Price Group, Inc. | 3.72% |
| 5 | Salesforce, Inc. | 3.45% |
| 6 | Humana Inc. | 3.23% |
| 7 | Berkshire Hathaway Inc. | 3.10% |
| 8 | NXP Semiconductors N.V. | 3.08% |
| 9 | Patterson-uti Energy, Inc. | 2.99% |
| 10 | Skyworks Solutions, Inc. | 2.97% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 35.4% of the fund. See all top 25 holdings and asset mix →